In today's quick episode, we talk about our new paper out now in JAMA Network Open titled "The Oncologic Drugs Advisory Committee Votes of April 2021—Implications for the Fate of Accelerated Approval"
4.08 Implications for the Fate of Accelerated Approval from the ODAC Votes of April 2021
Previous
Previous
4.09 Problems with the VISION Trial & Stool Transplant Plus Nivo for Metastatic Melanoma
Next
Next